129 related articles for article (PubMed ID: 29682174)
1. Esophageal squamous cell carcinoma transcriptome reveals the effect of
Nicolau-Neto P; Da Costa NM; de Souza Santos PT; Gonzaga IM; Ferreira MA; Guaraldi S; Moreira MA; Seuánez HN; Brewer L; Bergmann A; Boroni M; Mencalha AL; Kruel CDP; Lima SCS; Esposito D; Simão TA; Pinto LFR
Oncotarget; 2018 Mar; 9(24):16634-16647. PubMed ID: 29682174
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of FOXM1 as a target for malignant progression of esophageal squamous cell carcinoma.
Song L; Wang X; Feng Z
Oncol Lett; 2018 Apr; 15(4):5910-5914. PubMed ID: 29552222
[TBL] [Abstract][Full Text] [Related]
3. Derlin-1 is a target to improve radiotherapy effect of esophageal squamous cell carcinoma.
Dong Q; Fu L; Zhao Y; Liu Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Aug; 8(33):55135-55146. PubMed ID: 28903408
[TBL] [Abstract][Full Text] [Related]
4. Maternal Embryonic Leucine Zipper Kinase Promotes Tumor Growth and Metastasis via Stimulating FOXM1 Signaling in Esophageal Squamous Cell Carcinoma.
Chen L; Wei Q; Bi S; Xie S
Front Oncol; 2020; 10():10. PubMed ID: 32047721
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
[TBL] [Abstract][Full Text] [Related]
6. PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy.
Luo Q; Du R; Liu W; Huang G; Dong Z; Li X
Front Oncol; 2022; 12():852383. PubMed ID: 35392233
[TBL] [Abstract][Full Text] [Related]
7. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.
Yoshioka A; Miyata H; Doki Y; Yasuda T; Yamasaki M; Motoori M; Okada K; Matsuyama J; Makari Y; Sohma I; Takiguchi S; Fujiwara Y; Monden M
Oncol Rep; 2008 May; 19(5):1099-107. PubMed ID: 18425364
[TBL] [Abstract][Full Text] [Related]
8. UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1.
Nicolau-Neto P; Palumbo A; De Martino M; Esposito F; de Almeida Simão T; Fusco A; Nasciutti LE; Meireles Da Costa N; Ribeiro Pinto LF
Genes (Basel); 2018 Mar; 9(4):. PubMed ID: 29596365
[TBL] [Abstract][Full Text] [Related]
9. FoxM1 knockdown enhanced radiosensitivity of esophageal cancer by inducing apoptosis.
Qin Q; Chen H; Xu H; Zhang X; Chen J; Zhang C; Liu J; Xu L; Sun X
J Cancer; 2023; 14(3):454-463. PubMed ID: 36860922
[TBL] [Abstract][Full Text] [Related]
10. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
[TBL] [Abstract][Full Text] [Related]
11. LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Wang P; Ye H; Wang Y; Ren Y; Zhang J; Lu Z
Onco Targets Ther; 2019; 12():5215-5225. PubMed ID: 31308693
[No Abstract] [Full Text] [Related]
12. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
[TBL] [Abstract][Full Text] [Related]
13. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
[TBL] [Abstract][Full Text] [Related]
14. CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling.
Huang Y; Lin L; Shen Z; Li Y; Cao H; Peng L; Qiu Y; Cheng X; Meng M; Lu D; Yin D
Am J Cancer Res; 2020; 10(10):3328-3344. PubMed ID: 33163273
[TBL] [Abstract][Full Text] [Related]
15. VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma.
Liu ZC; Cao K; Xiao ZH; Qiao L; Wang XQ; Shang B; Jia Y; Wang Z
Oncotarget; 2017 Sep; 8(39):65642-65658. PubMed ID: 29029460
[TBL] [Abstract][Full Text] [Related]
16. DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by downregulating the EGFR/AKT pathway in esophageal squamous cell carcinoma.
Ng HY; Ko JM; Yu VZ; Ip JC; Dai W; Cal S; Lung ML
Int J Cancer; 2016 Jun; 138(12):2940-51. PubMed ID: 26856390
[TBL] [Abstract][Full Text] [Related]
17. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
18. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
19. DNA hypermethyation and silencing of
Otsubo T; Yamada K; Hagiwara T; Oshima K; Iida K; Nishikata K; Toyoda T; Igari T; Nohara K; Yamashita S; Hattori M; Dohi T; Kawamura YI
Oncotarget; 2017 Oct; 8(48):84434-84448. PubMed ID: 29137437
[TBL] [Abstract][Full Text] [Related]
20. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
